Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task

European Journal of Pharmacology

Volumn 282, Issue 1-3, 1995, Pages 185-191

  Hiramatsu, Masayuki ^a   Sasaki, Mayumi ^a   Kameyama, Tsutomu ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Cholinergic neuronal system; CO (carbon monoxide); Delayed amnesia; Dynorphin A (1 13); Learning; Nor binaltorphimine; Passive avoidance; Opioid receptor

Indexed keywords

CARBON MONOXIDE; DYNORPHIN[1-13]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE; OPIATE ANTAGONIST;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; TRAINING;

AMNESIA; ANIMAL; AVOIDANCE LEARNING; CARBON MONOXIDE; DYNORPHINS; MALE; MEMORY; MICE; MICE, INBRED STRAINS; NALTREXONE; PEPTIDE FRAGMENTS; REACTION TIME; RECEPTORS, OPIOID, KAPPA; RETENTION (PSYCHOLOGY); SUPPORT, NON-U.S. GOV'T;

EID: 0028977971     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00330-N     Document Type: Article

References (32)

1. Delayed memory dysfunction by transient hypoxia, and its prevention with forskolin
2. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats
3. The cholinergic hypothesis of geriatric memory dysfunction
4. Animal studies of brain acetylcholine and memory
5. Interactive effects of physical work and carbon monoxide on cognitive task performance
6. Alzheimer's disease: a disorder of cortical cholinergic innervation
7. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism
8. Delayed neurological deterioration following hypoxia
9. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse
10. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients
11. Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia
12. Differential effects of pimozide and SCH 23390 on acquisition of learning in mice
13. Dynorphin induces task-specific impairment of memory
14. Effects of successive carbon monoxide exposures on delayed neuronal death in mice under the maintenance of normal body temperature
15. Dynorphin A-(1–13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice
16. U-50, 488H, a κ-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice
17. Unlike β-endorphin, dynorphin 1–13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avoidance learning in rats
18. Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task
19. Cholinergic modulation of memory for step-down type passive avoidance task in mice
20. Methods used for the study of opioid receptors
21. Nicotinic systems and cognitive function
22. MK-801 ameliorates delayed amnesia, but potentiates acute amnesia induced by CO
23. Carbon monoxide-induced delayed amnesia, delayed neuronal death and change in acetylcholine concentration in mice
24. Cholinergic drug studies in dementia and depression
25. Influence of opioid peptides on learning and memory processes in the chick
26. Taking stock of cognition enhancers
27. Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and antagonist betacarboline
28. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity
29. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway
30. Scopolamine- and morphine-induced impairment of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists
31. Dynorphin A-(1–13) attenuates basal forebrain-lesion-induced amnesia n rats
32. Effects of NIK-247 on CO-induced impairment of passive avoidance in mice